Klimadynon

Dry Extract From Cimicifuga Racemosa (Black Cohosh), the active ingredient in Klimadynon, is a herbal botanical presented as a standardized dry extract for oral use. It is derived from the rhizome of the black cohosh plant and is traditionally employed to help alleviate menopausal discomforts such as hot flashes, night sweats, and mood changes in adult women.

GNH USA supplies Klimadynon as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity across global markets.

Klimadynon, a black cohosh dry extract, is used to support women experiencing menopausal symptoms.

- Menopausal hot flashes: may reduce the frequency and intensity of hot flashes. - Night sweats: may lessen excessive nighttime sweating. - Mood swings: may help improve mood stability during menopause.

Adverse reactions have been reported with oral black cohosh extracts. Most are mild and reversible.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient episodes. - Skin rash: mild erythema or itching. - Fatigue: occasional tiredness.

Serious or Rare Side Effects: - Liver injury: signs of hepatitis or elevated enzymes. - Severe allergic reaction: anaphylaxis, swelling of face or throat. - Blood clot formation: deep vein thrombosis. - Severe hypertension: sudden increase in blood pressure. - Acute pancreatitis: abdominal pain with elevated enzymes.

Safety considerations should be observed before and during therapy.

- Assess liver function: monitor hepatic enzymes before initiating and periodically during use. - Avoid in known hypersensitivity: discontinue if rash or swelling develops. - Caution in hormone‑sensitive conditions: evaluate risk in patients with breast or uterine cancer. - Do not use during pregnancy: insufficient safety data for fetal exposure. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Potential drug‑herb interactions may modify therapeutic outcomes.

Major Interactions (Avoid): - Concurrent use with hormonal contraceptives: may reduce contraceptive efficacy. - Combination with anticoagulants (e.g., warfarin): increased risk of bleeding.

Moderate Interactions (Monitor Closely): - Use with SSRIs or SNRIs: possible additive serotonergic effects. - Use with CYP450 substrates: potential alteration of drug metabolism. - Use with other herbal supplements: risk of additive side‑effects or pharmacodynamic overlap.